Deltagen Inc. reported consolidated unaudited earnings results for the third quarter ended September 30, 2012. For the quarter, the company reported consolidated revenues totaled $0.211 million. Loss from operations was $0.47 million.

Loss before provision for income taxes was $0.581 million. Net loss was $0.581 million. The revenues in the third quarter of 2012 were attributable primarily to license fees associated with the provision of knockout mice and related phenotypic data pursuant to orders placed by customers under the company's DeltaOne(TM) program.